Boc-Leu-(?)-Val-OH is a Boc-protected, amino-acid-derived peptide intermediate composed of leucine and valine connected through an unspecified intermediate residue at the central position, with the terminal carboxylic acid present as a free acid. The molecule bears a tert-butoxycarbonyl (Boc) protecting group on the N-terminus to control chemoselectivity during stepwise coupling, while the remaining amino and carboxyl functionalities are arranged to support further peptide bond formation and subsequent deprotection when required. In peptide synthesis workflows, this intermediate is used as a building block that provides defined side-chain functionality from leucine and valine while the protected N-terminus helps manage reactivity during assembly of longer peptide targets.
CAT No: CP27505
CAS No:82252-39-9
Synonyms/Alias:82252-39-9;Boc-Leu-(?)-Val-OH;BOC-LEU--VAL-OH;ZINC2526319
Boc-Leu-(?)-Val-OH is a Boc-protected amino acid building block designed for peptide and peptidomimetic assembly, featuring a leucine residue linked to a valine carboxylic acid terminus. The Boc group provides N-terminal protection for controlled coupling during stepwise synthesis, while the amino acid side chains support incorporation into hydrophobic peptide segments commonly used in structure-activity relationship studies. As a protected intermediate, it is typically handled as a synthetic precursor for generating defined dipeptide or extended peptide fragments with a specified backbone connectivity.
1. Peptide Fragment Synthesis
Boc-Leu-(?)-Val-OH is used by peptide chemistry groups to construct defined peptide segments where leucine-valine connectivity is required, particularly during solution-phase or automated fragment condensation workflows. The Boc-protected N-terminus enables sequential coupling while maintaining chemoselectivity, helping researchers prepare longer sequences with consistent end-group identity for downstream purification and characterization. This intermediate is especially practical when the target peptide design relies on hydrophobic residues to probe folding propensity, binding interfaces, or conformational preferences in SAR campaigns.
2. Fmoc-Compatible Library Building
Boc-Leu-(?)-Val-OH is frequently incorporated into peptide library synthesis strategies that require reliable handling of protected amino acid fragments as standardized building blocks. By supplying a pre-organized leucine-valine unit with a protected amino terminus, it supports parallel synthesis of multiple analogs where only other positions are varied, improving reproducibility across compound sets. Medicinal chemistry and chemical biology teams use this approach to generate focused libraries for structure-activity relationship mapping, enabling rapid iteration of peptide-like scaffolds with controlled sequence composition.
3. Pharmaceutical Intermediate Development
Boc-Leu-(?)-Val-OH serves as a practical pharmaceutical intermediate for custom peptide manufacturing and intermediate-scale preparation of sequence-defined fragments used in later assembly steps. Process development teams value such protected building blocks because they reduce variability in fragment identity and simplify downstream handoffs to subsequent coupling stages, which is important when preparing larger batches of defined intermediates for research-grade lead optimization. The protected Boc functionality supports robust synthetic workflows where controlled deprotection and coupling steps are coordinated to produce consistent intermediate profiles for purification and analytics.
4. Analytical Reference Material Preparation
Boc-Leu-(?)-Val-OH is also used in analytical method development and characterization workflows where defined peptide fragments are needed as reference standards for identity confirmation, impurity profiling, or method qualification. Laboratories developing LC-MS or HPLC methods for peptide synthesis monitoring often rely on well-defined protected intermediates to establish retention and fragmentation behavior for specific sequence elements. Using a characterized leucine-valine building block helps ensure that analytical signals can be assigned to the correct synthetic stage products during iterative synthesis and troubleshooting.
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Myotropic activity of allatostatins in tenebrionid beetles
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More